Ascension Ventures led the precision medicine technology provider's series C round, which included Social Capital Partnership and Safeguard Scientifics.
Ascension Ventures, the strategic investment arm of healthcare provider Ascension, has led a $25m series C round for US-based precision medicine technology developer Syapse.
Social Capital Partnership and Safeguard Scientifics also contributed to the round, which increased the company’s total funding to $39.5m. Social Capital Partnership led its $3m series A round in 2013 before joining Safeguard for a $10m series B the following year.
Syapse has created a software suite that allows health systems to streamline their operations, improve…
